1-3 of 3
Xudong Wei, MD
Close
Sort by
Journal Articles

Chidamide, Decitabine, Cytarabine, Aclarubicin, and Granulocyte Colony-Stimulating Factor (CDCAG) in Adults with Relapsed/Refractory Acute Myeloid Leukemia: Final Results from a Phase 1/2 Study

Lixin Wang, PhD MD, Guofeng Chen, MD, Jianliang Shen, MD PhD, Jianmin Luo, Meiyun Fang, MD, Xudong Wei, MD, Yinghua Li, MD, Zhuogang Liu, MD, Yin Zhang, MD, Sujun Gao, PhD, Xin Wang, MD PhD, Xiaoning Gao, MD PhD, Wei Zhou, MD, Yigai Ma, MD, Hui Liu, MD, Xinquan Li, MD PhD, Linhua Yang, MD, Li Yu, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2707.
https://doi.org/10.1182/blood-2018-99-111761
Published: 2018
Journal Articles

Compound Application of Thalidomide and Recombinant Human Interferon-α-1b, Interleukin-2 in Different Disease Status of Acute Myeloid Leukemia a Multi-Center Prospective Study of a New Combination of Old Drugs

Lin Chen, MD, Ruihua Mi, Xudong Wei, MD PhD, Qingsong Ying, Fangfang Yuan, MD, Lijie Liang, Mengjuan Li, Delong Liu, MD PhD, Yongping Song
Journal: Blood
Blood (2018) 132 (Supplement 1): 5219.
https://doi.org/10.1182/blood-2018-99-114021
Published: 2018
Journal Articles

Flow Cytometric Detection of the Expression of CXCR4 on CD34 + Cells and the Distribution of Lymphocyte Subsets in Allogeneic Hematological Grafts.

Lulu Lu, PhD, MD, Yongping Song, MD and PhD, Baogen Ma, MD, Xiongpeng Zhu, MD and PhD, Xudong Wei, MD and PhD, Zhizhe Chen, MD
Journal: Blood
Blood (2005) 106 (11): 5195.
https://doi.org/10.1182/blood.V106.11.5195.5195
Published: 2005